Skip to main content

21-09-2020 | ESMO 2020 | Conference coverage | Video

ADAURA CNS analysis: Key messages and future directions

Masahiro Tsuboi discusses the clinical implications of the primary and CNS analyses of the ADAURA trial of adjuvant osimertinib in EGFR-mutated non-small-cell lung cancer and outlines the key next steps (2:33).

Read transcript

Image Credits